Lupin Ltd
NSE:LUPIN

Watchlist Manager
Lupin Ltd Logo
Lupin Ltd
NSE:LUPIN
Watchlist
Price: 2 071.35 INR 1.39% Market Closed
Market Cap: 944.3B INR
Have any thoughts about
Lupin Ltd?
Write Note

Relative Value

The Relative Value of one LUPIN stock under the Base Case scenario is 1 998.28 INR. Compared to the current market price of 2 071.35 INR, Lupin Ltd is Overvalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LUPIN Relative Value
Base Case
1 998.28 INR
Overvaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
4
vs Industry
30
Median 3Y
2.5
Median 5Y
2.7
Industry
2.5
Forward
4.1
vs History
28
vs Industry
10
Median 3Y
38.7
Median 5Y
33.4
Industry
21.9
Forward
32.6
vs History
38
vs Industry
20
Median 3Y
19.8
Median 5Y
21.7
Industry
16.5
vs History
9
vs Industry
5
Median 3Y
62.3
Median 5Y
36
Industry
23.6
vs History
4
vs Industry
13
Median 3Y
3.5
Median 5Y
3.3
Industry
2.1
vs History
4
vs Industry
28
Median 3Y
2.6
Median 5Y
2.6
Industry
2.6
Forward
4.2
vs History
4
vs Industry
34
Median 3Y
4.2
Median 5Y
4.2
Industry
5.2
vs History
17
vs Industry
17
Median 3Y
18.8
Median 5Y
18.3
Industry
13.3
Forward
18.5
vs History
41
vs Industry
13
Median 3Y
30.9
Median 5Y
29.3
Industry
16.6
Forward
25.9
vs History
34
vs Industry
21
Median 3Y
20.3
Median 5Y
22.1
Industry
15.6
vs History
34
vs Industry
15
Median 3Y
27.2
Median 5Y
27.2
Industry
19.1
vs History
4
vs Industry
19
Median 3Y
2.5
Median 5Y
2.4
Industry
1.9

Multiples Across Competitors

LUPIN Competitors Multiples
Lupin Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Lupin Ltd
NSE:LUPIN
943.9B INR 4.5 41.7 22.4 31.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IN
Lupin Ltd
NSE:LUPIN
Average P/E: 33.6
41.7
97%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top